Response Genetics Stock Price, News & Analysis (OTCMKTS:RGDXQ)

$0.0003 0.00 (0.00 %)
(As of 12/14/2017 04:00 PM ET)
Previous Close$0.00
Today's Range$0.00 - $0.00
52-Week RangeN/A
Volume21,000 shs
Average Volume35,963 shs
Market Capitalization$20,000.00
P/E RatioN/A
Dividend YieldN/A
Beta-0.56

About Response Genetics (OTCMKTS:RGDXQ)

Response Genetics, Inc. is a life science company. The Company is engaged in the research, development, marketing and sale of pharmacogenomic tests for use in the treatment of cancer. To generate pharmacogenomic information from patient specimens for these tests, the Company uses its own methods for the extraction and analysis of nucleic acids and accessing the genetic information available from each patient sample. The Company's platforms include analysis of single biomarkers using the polymerase chain reaction method, as well as gene interrogation using microarray methods and fluorescence in situ hybridization (FISH) from paraffin or frozen tissue specimens. The Company is engaged in selling ResponseDX diagnostic testing products. The Company provides pharmacogenomic clinical trial testing services to pharmaceutical companies in the United States, Asia and Europe.

Receive RGDXQ News and Ratings via Email

Sign-up to receive the latest news and ratings for RGDXQ and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Laboratories & Research
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:RGDXQ
CUSIPN/A
Phone323-224-3900

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$16.72 million
Price / Sales0.00
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding Shares38,790,000

Response Genetics (OTCMKTS:RGDXQ) Frequently Asked Questions

What is Response Genetics' stock symbol?

Response Genetics trades on the OTCMKTS under the ticker symbol "RGDXQ."

How were Response Genetics' earnings last quarter?

Response Genetics, Inc. (OTCMKTS:RGDXQ) posted its earnings results on Tuesday, March, 31st. The medical research company reported ($0.09) earnings per share (EPS) for the quarter. The medical research company earned $4.10 million during the quarter. View Response Genetics' Earnings History.

Who are some of Response Genetics' key competitors?

Who are Response Genetics' key executives?

Response Genetics' management team includes the folowing people:

  • Thomas A. Bologna, Chairman of the Board, Chief Executive Officer (Age 66)
  • Kevin Roy Harris, Chief Financial Officer, Vice President (Age 47)
  • Adanech Getachew, General Counsel (Age 37)
  • Kirk K. Calhoun, Lead Independent Director (Age 73)
  • Michael Serruya, Director (Age 51)
  • Sam Chawla, Independent Director (Age 41)
  • David R Schreiber, Independent Director (Age 55)
  • Richard A. van den Broek, Independent Director (Age 49)

How do I buy Response Genetics stock?

Shares of Response Genetics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Response Genetics' stock price today?

One share of Response Genetics stock can currently be purchased for approximately $0.00.

How big of a company is Response Genetics?

Response Genetics has a market capitalization of $20,000.00 and generates $16.72 million in revenue each year.

How can I contact Response Genetics?

Response Genetics' mailing address is 1640 MARENGO ST 7TH FLOOR, LOS ANGELES CA, 90033. The medical research company can be reached via phone at 323-224-3900 or via email at [email protected]


MarketBeat Community Rating for Response Genetics (RGDXQ)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  25 (Vote Outperform)
Underperform Votes:  14 (Vote Underperform)
Total Votes:  39
MarketBeat's community ratings are surveys of what our community members think about Response Genetics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Response Genetics (OTCMKTS:RGDXQ) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Response Genetics (OTCMKTS:RGDXQ) Earnings History and Estimates Chart

Earnings by Quarter for Response Genetics (OTCMKTS:RGDXQ)

Response Genetics (OTCMKTS RGDXQ) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/14/2015Q115($0.10)$3.90 million$3.80 millionViewListenView Earnings Details
3/31/2015Q414($0.09)$4.10 millionViewN/AView Earnings Details
8/14/2014Q214($0.08)$3.90 million$4.30 millionViewN/AView Earnings Details
5/8/2014Q114($0.06)($0.03)$5.50 million$3.90 millionViewN/AView Earnings Details
3/20/2014Q413($0.07)($0.09)$5.30 million$4.80 millionViewN/AView Earnings Details
11/7/2013Q313($0.07)($0.08)$5.40 million$4.10 millionViewN/AView Earnings Details
8/8/2013Q2 2013($0.04)($0.11)$5.40 million$5.30 millionViewN/AView Earnings Details
5/14/2013Q1 2013($0.04)($0.03)$4.92 million$5.60 millionViewN/AView Earnings Details
11/13/2012Q312($0.07)($0.05)$4.50 million$5.40 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Response Genetics (OTCMKTS:RGDXQ) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Response Genetics (OTCMKTS:RGDXQ)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Response Genetics (OTCMKTS RGDXQ) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 4.85%
Insider Trades by Quarter for Response Genetics (OTCMKTS:RGDXQ)

Response Genetics (OTCMKTS RGDXQ) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/23/2013Austin W & Greenhouse Da MarxeMajor ShareholderSell134,991$1.11$149,840.01View SEC Filing  
12/19/2013Austin W & Greenhouse Da MarxeMajor ShareholderSell135,666$1.18$160,085.88View SEC Filing  
12/16/2013Austin W & Greenhouse Da MarxeMajor ShareholderSell353,677$1.17$413,802.09View SEC Filing  
11/27/2012Austin W & Greenhouse Da MarxeMajor ShareholderBuy463,278$1.02$472,543.56View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Response Genetics (OTCMKTS RGDXQ) News Headlines

Source:
No headlines for this company have been tracked by MarketBeat.com

SEC Filings

Response Genetics (OTCMKTS:RGDXQ) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Response Genetics (OTCMKTS RGDXQ) Stock Chart for Thursday, December, 14, 2017

Loading chart…

This page was last updated on 12/14/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.